PGYFebruary 26, 2026 at 4:55 PM UTCFinancial Services

Pagaya's Auto ABS Secures KBRA Ratings, Reinforcing Funding but Underscoring Persistent Risks

Read source article

What happened

KBRA assigned preliminary ratings to Pagaya's new auto loan ABS transaction, RPM 2026-1, with credit enhancement levels ranging from 89.05% for senior notes to 3.25% for junior notes, indicating structured investor protection. This move aligns with Pagaya's strategy to diversify funding through securitization, as detailed in the DeepValue report, which highlights the company's reliance on volatile credit markets and recent GAAP profitability streak. However, the announcement lacks critical details on pricing spreads and investor demand, masking whether funding costs have improved or worsened amid high leverage and economic uncertainty. While the transaction supports network volume growth and fee revenue, it does not address the core vulnerabilities of elevated net debt/EBITDA at 7.26x and sensitivity to consumer credit cycles. Investors should see this as a routine capital markets activity that maintains operational momentum but fails to justify the stock's premium valuation or alter the cautious wait-and-see stance.

Implication

For investors, this ABS deal demonstrates Pagaya's ongoing ability to execute securitizations, which is essential for funding network volume growth and sustaining recent profitability. However, without disclosed spreads, it remains uncertain if funding costs are favorable or if investor appetite is weakening, a key early warning indicator noted in the DeepValue report. The high credit enhancement on senior notes suggests continued investor caution, reflecting persistent concerns over credit risk and the company's 8.875% senior notes coupon signaling elevated risk premia. This transaction may temporarily bolster GAAP earnings but does not reduce the substantial on-balance-sheet exposures or improve the margin of safety, leaving equity vulnerable to downside scenarios. Ultimately, while funding access is confirmed, the wait recommendation stands as valuation already embeds optimistic assumptions, and any deterioration in credit performance or ABS spreads could swiftly erode shareholder value.

Thesis delta

The new ABS ratings do not shift the investment thesis; they reinforce the base case assumption of stable funding access but offer no evidence of improved economics or reduced risks. Investors should monitor upcoming pricing details and credit performance for signs of spread pressure or impairment trends, which could trigger the bear scenario. No change to the wait recommendation is warranted until more quarters of resilient margins and deleveraging are demonstrated.

Confidence

High